Our partner created a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
This critical hire led and drove the Drug Substance strategy for peptides and oligonucleotides, ensuring effective communication, connection, and collaboration with CMO partners across global locations.
days until hired candidate presented
candidates presented
days until search completed